（来源：经济参考报） "医保部门始终紧盯前沿医疗技术发展，以政策创新推动技术从临床探索走向规模化应用，脑机接口技 术的支持过程成为典型范例。"谢章澍说。 事实上，早在2025年3月，医保部门就率先设立了脑机接口的相关价格和收费依据，解决了技术应用付 费难题；当年9月实现医保结算赋码，12月已有28个省份制定具体收费项目，推动技术在全国范围内铺 开应用。 "这体现了医保部门对未来产业的前瞻性布局。除脑机接口外，远程操作、质子重离子治疗、CAR-T肿 瘤治疗等一系列新技术、新药品也被纳入医保支持范畴，让群众切实享受到创新成果。"谢章澍表示。 在支持国内创新的同时，医保部门还积极搭建国际化平台，推动中国医药创新成果走向世界。此外，真 实世界医保综合价值评价作为医保目录准入、价格立项等医保决策的重要证据，既为创新技术提供了进 入临床收费的依据，也助力科学定价，为医保基金价值购买服务。 "展望'十五五'，医疗保障部门将继续深化'政策引导'与'价值评价'的双轮驱动战略，继续优化对脑机接 口等创新技术的价格支付政策，并积极开展真实世界医保综合价值评价，为医保决策科学化提供有力支 持。"谢章澍说。 "作为主要的民生保障部门， ...

Core Insights - The 2025 Beijing-Tianjin-Hebei Innovation Medical Transformation and Industry Promotion Competition concluded successfully, with a focus on creating a collaborative medical industry demonstration zone and developing new productive forces in health [1] - Minsheng Bank Beijing Branch provided strategic support throughout the event, leveraging its expertise in "finance + technology" to enhance the transformation of medical innovations [1] Group 1: Event Overview - The competition attracted 405 high-quality projects from both domestic and international participants, covering four key areas: medical devices and intelligent manufacturing, innovative pharmaceuticals and biological products, AI healthcare and health management, and traditional Chinese medicine innovation [1] - After three stages of evaluation, 35 projects were awarded prizes in the final competition [1] Group 2: Minsheng Bank's Role - Minsheng Bank Beijing Branch has positioned itself as a crucial link between innovation and industry, focusing on the integration of financial power with the innovation, industry, and resource chains in the Beijing-Tianjin-Hebei region [1] - The bank has introduced measures to address the cross-border development needs of medical innovation enterprises, including automated online collection, material fee exemptions for quality enterprises, and integrated cross-border financing services [1] Group 3: Financial Services for Medical Innovation - The bank has developed a comprehensive service model that integrates settlement, financing, and technology to alleviate financial pressures faced by the pharmaceutical industry [2] - Moving forward, Minsheng Bank Beijing Branch aims to continuously optimize its medical financial service system to support high-quality development in the regional pharmaceutical and health industry [2]

Core Viewpoint - Guangdong Province is advancing healthcare innovation through the integration of AI, surgical robots, and mobile medical solutions to enhance eye health services and address disparities in healthcare access [1][4][9]. Group 1: Technological Innovations - The event showcased innovations in healthcare, including stem cell regeneration, AI diagnostics, surgical robots, and mobile eye clinics [3][4]. - Guangdong is prioritizing technological innovation as a core engine for high-quality healthcare development, focusing on clinical research, result transformation, and innovative medical device applications [10][12]. Group 2: Clinical Research and Development - Guangdong has established a robust clinical research support system, with nearly 50,000 registered clinical research projects and a leading number of approved stem cell clinical research projects in China [13][14]. - The province has implemented national pilot programs to enhance the efficiency of innovative drug and device development [15]. Group 3: Medical Technology Transformation - Guangdong is promoting equal innovation transformation policies for medical institutions and research organizations, including training for medical technology managers and the establishment of "innovation transformation clinics" [16][18]. - The province has introduced 125 types of medical products from Hong Kong and Macau, benefiting over 10,000 patients [22]. Group 4: Breakthroughs in Eye Disease Treatment - The Zhongshan University Eye Center has achieved global leadership in new technologies, drugs, and treatment models, including stem cell technology for congenital cataracts, which has shown a 30% improvement in long-term vision compared to traditional surgery [28][30][31]. - The center has developed the world's first eye drops that can reverse cataracts and new glaucoma medications that break international monopolies, currently in clinical trials [33][34][36]. Group 5: Mobile Healthcare Solutions - To address healthcare access issues, the Zhongshan Eye Center has developed an intelligent medical system utilizing AI and 5G technology, including a smart eye examination vehicle that has served over 16,000 infants [44][47]. - The center is also pioneering a high-precision eye surgery robot that enhances surgical safety and success rates, with plans for remote operations in underserved areas [51][54]. Group 6: Future Plans and Collaborations - The center aims to establish a comprehensive mobile healthcare system, including aerial, satellite, and maritime solutions for eye health, with plans for the first flight of the "Chinese Eye Flying Hospital" by the end of the year [57][60].